Sophie Dobiasch1, Nicole L Goerig2, Rainer Fietkau2, Stephanie E Combs3,4. 1. Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany. 2. Department of Radiation Oncology, Universitätsklinikum Erlangen, Friedrich-Alexander-Universität Erlangen-Nürnberg, Universitätsstraße 27, 91054, Erlangen, Germany. 3. Department of Radiation Oncology, Klinikum rechts der Isar, Technical University of Munich (TUM), Ismaninger Straße 22, 81675, Munich, Germany. Stephanie.combs@tum.de. 4. Institute of Innovative Radiotherapy (iRT), Department of Radiation Sciences (DRS), Helmholtz Zentrum München, Ingolstädter Landstraße 1, 85764, Neuherberg, Germany. Stephanie.combs@tum.de.
Abstract
BACKGROUND: Pancreatic cancer is one of the most aggressive human tumors and the incidence has increased over the last 6 years. In the majority of cases the disease is already in an advanced stage at the time of diagnosis where surgery, the only curative treatment, is no longer an option and explains the still abysmal overall survival. The role of radiation therapy as treatment option for patients with pancreatic cancer is controversially discussed although radiation oncology has emerged as a central pillar in the combined oncological treatment. PURPOSE: The present manuscript gives an overview of advanced radiotherapeutic strategies in the context of chemotherapy and surgery according to the current American Society of Clinical Oncology (ASCO) guidelines in comparison with the German guidelines and to elucidate the role of radiation therapy for the treatment of pancreatic cancer. CONCLUSION: Advanced modern radiotherapeutic techniques in combination with individualized high-precision radiation concepts are new therapeutic approaches for pancreatic cancer in a multimodal setting with tolerable side effects. Several clinical studies together with experimental approaches are in process, to deliver further evidence and ultimately allow true personalized medicine.
BACKGROUND:Pancreatic cancer is one of the most aggressive humantumors and the incidence has increased over the last 6 years. In the majority of cases the disease is already in an advanced stage at the time of diagnosis where surgery, the only curative treatment, is no longer an option and explains the still abysmal overall survival. The role of radiation therapy as treatment option for patients with pancreatic cancer is controversially discussed although radiation oncology has emerged as a central pillar in the combined oncological treatment. PURPOSE: The present manuscript gives an overview of advanced radiotherapeutic strategies in the context of chemotherapy and surgery according to the current American Society of Clinical Oncology (ASCO) guidelines in comparison with the German guidelines and to elucidate the role of radiation therapy for the treatment of pancreatic cancer. CONCLUSION: Advanced modern radiotherapeutic techniques in combination with individualized high-precision radiation concepts are new therapeutic approaches for pancreatic cancer in a multimodal setting with tolerable side effects. Several clinical studies together with experimental approaches are in process, to deliver further evidence and ultimately allow true personalized medicine.
Authors: M Reni; M G Panucci; A J Ferreri; G Balzano; P Passoni; G M Cattaneo; S Cordio; U Scaglietti; A Zerbi; G L Ceresoli; C Fiorino; R Calandrino; C Staudacher; E Villa; V Di Carlo Journal: Int J Radiat Oncol Biol Phys Date: 2001-07-01 Impact factor: 7.038
Authors: Davendra P S Sohal; Pamela B Mangu; Alok A Khorana; Manish A Shah; Philip A Philip; Eileen M O'Reilly; Hope E Uronis; Ramesh K Ramanathan; Christopher H Crane; Anitra Engebretson; Joseph T Ruggiero; Mehmet S Copur; Michelle Lau; Susan Urba; Daniel Laheru Journal: J Clin Oncol Date: 2016-05-31 Impact factor: 44.544
Authors: Muhammad S Beg; Arjun Gupta; David Sher; Sadia Ali; Saad Khan; Ang Gao; Tyler Stewart; Chul Ahn; Jarett Berry; Eric M Mortensen Journal: Am J Clin Oncol Date: 2018-08 Impact factor: 2.339
Authors: Christian Wittekind; Carolyn Compton; Phil Quirke; Iris Nagtegaal; Susanne Merkel; Paul Hermanek; Leslie H Sobin Journal: Cancer Date: 2009-08-01 Impact factor: 6.860
Authors: Stephanie E Combs; Daniel Habermehl; Kerstin A Kessel; Frank Bergmann; Jens Werner; Patrick Naumann; Dirk Jäger; Markus W Büchler; Jürgen Debus Journal: Ann Surg Oncol Date: 2014-06-11 Impact factor: 5.344
Authors: Falk Roeder; Carmen Timke; Matthias Uhl; Gregor Habl; Frank W Hensley; Markus W Buechler; Robert Krempien; Peter E Huber; Juergen Debus; Jens Werner Journal: BMC Cancer Date: 2012-07-18 Impact factor: 4.430
Authors: Malolan S Rajagopalan; Dwight E Heron; Rodney E Wegner; Herbert J Zeh; Nathan Bahary; Alyssa M Krasinskas; Barry Lembersky; Randall Brand; A James Moser; Annette E Quinn; Steven A Burton Journal: Radiat Oncol Date: 2013-10-31 Impact factor: 3.481
Authors: S Dobiasch; S Kampfer; D Habermehl; M N Duma; K Felix; A Strauss; D Schilling; J J Wilkens; S E Combs Journal: Strahlenther Onkol Date: 2018-06-11 Impact factor: 3.621
Authors: Christina Leitzen; Timo Wilhelm-Buchstab; Sabina Stumpf; Martina Heimann; David Koch; Christopher Schmeel; Birgit Simon; Susanne Vornholt; Stephan Garbe; Fred Röhner; Felix Schoroth; Hans Heinz Schild; Heinrich Schüller; Thomas Müdder Journal: Strahlenther Onkol Date: 2019-03-26 Impact factor: 3.621
Authors: U A Wittel; D Lubgan; M Ghadimi; O Belyaev; W Uhl; W O Bechstein; R Grützmann; W M Hohenberger; A Schmid; L Jacobasch; R S Croner; A Reinacher-Schick; U T Hopt; A Pirkl; H Oettle; R Fietkau; H Golcher Journal: BMC Cancer Date: 2019-10-22 Impact factor: 4.430
Authors: Patrick Naumann; Jonathan Eberlein; Benjamin Farnia; Jakob Liermann; Thilo Hackert; Jürgen Debus; Stephanie E Combs Journal: Cancers (Basel) Date: 2019-10-26 Impact factor: 6.639
Authors: Svenja Wiechmann; Elena Saupp; Daniela Schilling; Stephanie Heinzlmeir; Günter Schneider; Roland M Schmid; Stephanie E Combs; Bernhard Kuster; Sophie Dobiasch Journal: Mol Cell Proteomics Date: 2020-07-10 Impact factor: 5.911
Authors: R Fietkau; R Grützmann; U A Wittel; R S Croner; L Jacobasch; U P Neumann; A Reinacher-Schick; D Imhoff; S Boeck; L Keilholz; H Oettle; W M Hohenberger; H Golcher; W O Bechstein; W Uhl; A Pirkl; W Adler; S Semrau; S Rutzner; M Ghadimi; D Lubgan Journal: Strahlenther Onkol Date: 2020-09-10 Impact factor: 3.621